Clinical Trial Update: Evaluation of Maxy-G34 in Breast Cancer Patients Treated With TAC (Docetaxel, Adriamycin, Cyclophosphamide) Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Maxy-G34 in breast cancer patients treated with the TAC chemotherapy regimen (docetaxel, doxorubicin, cyclophosphamide). Statu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Maxy-G34

Snippet

Sponsor: Maxygen Holdings Ltd. | Conditions: Chemotherapy-Induced Neutropenia, Breast Cancer | Phase 2 | Status: UNKNOWN